A detailed history of Black Rock Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Black Rock Inc. holds 65,274,385 shares of LLY stock, worth $50.3 Billion. This represents 1.2% of its overall portfolio holdings.

Number of Shares
65,274,385
Previous 64,366,433 1.41%
Holding current value
$50.3 Billion
Previous $37.5 Billion 35.34%
% of portfolio
1.2%
Previous 0.97%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $538 Million - $719 Million
907,952 Added 1.41%
65,274,385 $50.8 Billion
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $687 Million - $810 Million
-1,307,501 Reduced 1.99%
64,366,433 $37.5 Billion
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $531 Million - $732 Million
1,222,210 Added 1.9%
65,673,934 $35.3 Billion
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $393 Million - $525 Million
-1,119,801 Reduced 1.71%
64,451,724 $30.2 Billion
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $152 Million - $179 Million
490,044 Added 0.75%
65,571,525 $22.5 Billion
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $560 Million - $652 Million
1,740,348 Added 2.75%
65,081,481 $23.8 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $122 Million - $139 Million
-410,577 Reduced 0.64%
63,341,133 $20.5 Billion
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $68.2 Million - $80.1 Million
-244,609 Reduced 0.38%
63,751,710 $20.7 Billion
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $85.4 Million - $106 Million
363,797 Added 0.57%
63,996,319 $18.3 Billion
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $827 Million - $1.03 Billion
3,676,934 Added 6.13%
63,632,522 $17.6 Billion
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $215 Million - $265 Million
-972,069 Reduced 1.6%
59,955,588 $13.9 Billion
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $11 Billion - $14.2 Billion
60,927,657 New
60,927,657 $14 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $732B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.